Linagliptin and Metformin Hydrochloride "'"''''"

Linagliptin and Metformin Hydrochloride 
LINALIGLIP M 5/500  are medications commonly used in combination to help manage type 2 diabetes. They work together to control blood sugar levels by addressing different aspects of the disease.
Linagliptin is a medication classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the DPP-4 enzyme, which breaks down incretin hormones. Incretin hormones play a role in regulating blood sugar by stimulating the release of insulin and reducing the production of glucagon after meals. By inhibiting DPP-4, linagliptin increases the availability of these incretin hormones, which helps lower blood sugar levels.
Metformin Hydrochloride is a commonly prescribed oral antidiabetic medication that belongs to a class of drugs known as biguanides. Metformin primarily works by reducing the amount of sugar produced by the liver and improving the body's sensitivity to insulin. This results in decreased sugar production by the liver and enhanced utilization of sugar by the body's cells, which, in turn, helps lower blood sugar levels.
The combination of LINALIGLIP M 5/500  is often recommended for individuals with type 2 diabetes when lifestyle modifications, such as diet and exercise, are insufficient to adequately control blood sugar levels. This combination medication can provide more effective blood sugar control by targeting different aspects of glucose regulation.
For further information please contact:
info@sterispharma.com
order now: -  https://www.sterisonline.com/product/linaliglip-m-5-500-134301